Eisai Inc.

This study tests a new drug called MORAb-202 for people with certain solid tumors, including ovarian, endometrial, lung, and breast cancers. The drug works by targeting a protein on cancer cells to deliver chemotherapy directly. The trial aims to find the safest and most effectiv…

This study is testing whether adding perampanel to current treatment can reduce seizures by at least half in children aged 1 month to 18 years with epilepsy. About 100 children will take part. The goal is to see if this medicine helps control seizures better than existing treatme…

This study tests an experimental drug called E2086 in 64 adults with narcolepsy to see if it can reduce excessive daytime sleepiness. Participants will receive either the drug or a placebo for 4 weeks, and their ability to stay awake will be measured using a standard test. The go…

This early-stage study tests a single dose of an experimental oral drug called E1018 in 32 healthy adults aged 18 to 55. The main goal is to check if the drug is safe and how the body absorbs and removes it. No treatment or prevention benefit is expected for participants. The res…

This study gives a single dose of a radiolabeled drug (E2086) to 10 healthy men to see how it is broken down and removed from the body. Researchers will measure the drug and its byproducts in blood, urine, and stool. The goal is to understand the drug's metabolism and excretion, …